Anne Wojcicki regains control of 23andme with bankruptcy of $ 305 million

23andme co -founder Ann Wajiki It is scheduled to regain control of its company in the DNA test after a non -profit organization that controls competitors at the bankruptcy auction.

The TTAM Research Institute, a generally -based general interest company based in California and its leadership, won by selling all Co. Holding 23ndme Holding, including Personal Genome Service (PGS), research services business lines and Lemonaid Health, for $ 305 million, from the highest medicines of the amount of $ 256 million.

Once the court approved it, the final agreement with TTAM will cancel the previously announced acquisition and the basic assets purchase agreement with Regeneron, DNA test company announced.

23DME bankruptcy: Will your private data be protected?

WoJCICKI participated in the establishment of the company in 2006, three years after the first human genome sequence, to help people get to know their ancestors. I sat on his head until the company advanced Chapter 11 bankruptcy In March.

As part of the bankruptcy protection procedures, the genetic test company has sought a new owner. WoJCICKI is intentionally dissolved to be in a better position to provide bids for ownership in her previous company.

“I am a supporter of the company and I intend to be bidding. I have resigned as a CEO of the company so that I can be in the best position to follow the company as an independent bidding,” WojCicki was published in X while she was resigned in March.

Despite the decrease in bankruptcy, Mark Jensen, Chairman and Member of the Special Committee of the 23ndme Board of Directors, praised WojCICKI, saying that it is “in a good position to develop the constituent company’s vision to help people reach health benefits and acquire them through a greater understanding of the human genome.”

23ndme files for bankruptcy where California urging customers to delete data

23andme will start the next chapter as a non -profit organization. TTAM also agreed to adopt additional privacy guarantees to promote protection for customer data and privacy as part of its deal.

Under the agreement, TTAM will honor the current 23ndme policies that allow individuals to delete their account, genetic data and research subscription.

In addition, all customers will be sent by e -mail at least a working day before the deal is closed in detail about the role of TTAM as well as its commitment to privacy options. Email messages will also include instructions on how to delete data or cancel the search.

TTAM also agreed that if the company has passed by bankruptcy or change ownership, it will not sell or share genetic data unless the new owner of the US -based organization follows the same rules of privacy and extinguishes all laws.

TTAM will create a consulting council for consumer privacy and will implement privacy procedures, notify clients of material changes, reduce data violations, and prepare annual reports that can be provided to public lawyers upon request.

Customers will be granted for free Control of experimental identity theftAccording to the conditions of the deal.

Get Fox Business on the Go by clicking here

Meanwhile, TTAM will continue to use the 23ndme policy of allowing the use of non -specific data for biological research by research scientists at academic universities and other non -profit organizations. It will also reject donations from individuals or companies in the specific countries.